Investigations into the impact of menopause on the brain have yielded a new way to treat troublesome symptoms without hormones.
Credit: SpeedKingsz/Shutterstock
That transition can bring a complex constellation of symptoms of varying intensity and duration — including fatigue, anxiety, headaches, and hot flushes, among others. Hot flushes are the most common symptom, and can feel as though a wave of heat has suddenly hit the upper body, leaving women feeling hot, flushed, and sweaty. Some people also feel light-headed and experience heart palpitations., sex, exercise and socializing.
In the 1990s, neuropathologist Naomi Rance at the University of Arizona in Tucson found a group of brain cells that were larger in the brains of post-menopausal women than in those of pre-menopausal women. Rance went on to find that these cells — called KNDy neurons — respond to a molecule called neurokinin B, and that blocking the receptor that allows those neurons to perceive neurokinin B can block symptoms akin to hot flushes in rats.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA approves first-of-its-kind drug to treat hot flashesWomen have suffered for centuries with hot flashes, one of the most common symptoms of menopause, without many treatment options. Now, the U.S. Food and Drug Administration has approved a first-of-its-kind drug, fezolinetant, sold under the brand name Veozah, to treat moderate to severe hot flashes during menopause. The drug, a pill taken once a day, is hormone-free, which makes it promising for women who cannot take hormone treatment because of other underlying health concerns, such as a prior history of strokes, heart attacks or blood clots.
Weiterlesen »
FDA approves first-of-its-kind drug to treat hot flashesThe FDA has approved a first-of-its-kind drug to treat moderate to severe hot flashes during menopause.
Weiterlesen »
FDA Moves to Curb Misuse of ADHD MedsThe FDA has unveiled fresh measures aimed at tackling persistent worries surrounding the improper use, abuse, addiction, and overdose of prescription stimulants prescribed for ADHD treatment. TwitteRx
Weiterlesen »
FDA Clears Renuvion APR Handpiece for Use After LiposuctionThe agency’s update on Wednesday follows three updates on the Renuvion/J-Plasma system in 2022.
Weiterlesen »
Sarepta stock soars 30% premarket after FDA panel backs accelerated approval for Duchenne muscular dystrophy therapySarepta Therapeutics Inc.’s stock soared 30% premarket Monday, after a U.S. Food and Drug Administration panel voted 8-6 in favor of accelerated approval for...
Weiterlesen »
FDA issues notice for recalled baby formula distributed out of NashvilleRECALL: This recalled product was distributed from its Nashville Division only to independent retailers located in Alabama, Georgia, Indiana, Kentucky, Ohio, Tennessee, Virginia, and West Virginia.
Weiterlesen »